Get started
Author

Antoni Figuerola

Observed names: A Figuerola, Antoni A. Figuerola, Figuerola, Antoni
OpenAlex ID: A5111982628
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
2020 · David Adams, Michael Polydefkis, et al. · The Lancet Neurology · 159
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
2025 · David Adams, Jonas Wixner, et al. · JAMA Neurology · 40
PDF
Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden
2021 · Juan González-Moreno, Aina Gaya-Barroso, et al. · Orphanet Journal of Rare Diseases · 16
PDF
Multidisciplinary approach in the management of hATTR
2020 · Ines Losada, Juan González‐Moreno, et al. · European Journal of Clinical Investigation · 10
Significant reduction in proteinuria after treatment with tafamidis
2019 · Asuncion Ferrer-Nadal, Tomas Ripoll, et al. · Amyloid · 8
Validating the usefulness of Sudoscan in ATTRv: a single centre experience
2024 · Elena Moreno-Moraleda, Juan González-Moreno, et al. · Neurological Sciences · 5
Real-Time Three-Dimensional Transesophageal Echocardiographic Imaging of Cor Triatriatum and Persistent Left Superior Vena Cava
2010 · Pere Pericas, Antonio Rodríguez-Fernández, et al. · Journal of the American Society of Echocardiography · 4
Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report
2019 · Eugenia Cisneros-Barroso, Inés Losada-López, et al. · Amyloid · 2
Val50Met Hereditary Transthyretin Amyloidosis: Not Just a Medical Problem, but a Psychosocial Burden
2020 · J González-Moreno, I Losada-López, et al. · Research Square
PDF
Sp198significant Reduction in Proteinuria After Treatment With Tafamidis
2019 · Asuncion Ferrer-Nadal, Tomas Ripoll, et al. · Nephrology Dialysis Transplantation
Works count: 13
Citation count: 244
H-index: 5
I10-index: 4
Year
Topic
Type